Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.

Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.

Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.

Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.

Abstract: A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary, a secondary, and a tertiary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the integral leads are inserted through the primary incision and routed subcutaneously to desired nerve regions along desired paths. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve regions and at least three of the nerves associated therewith to achieve a desired pain reduction response from the patient.

Abstract: An external charger system is disclosed comprising an external charger with an internal charging coil, as well as an output port coupleable to one of a plurality of types of external accessory charging coils of varying shapes and sizes. If the internal charging coil of the external charger is sufficient for a given patient's charging needs, the accessory charging coils may be detached from the external charger, and the external charger may serve as a standalone self-contained external charger. The external charger can automatically detect which of the plurality of types of accessory charging coils is connected, and can adjust its operation accordingly. This versatile design allows the external charger system to be used by large numbers of patients, even if their particular implant charging scenarios are different.

Abstract: An external charger system is disclosed comprising an external charger with an internal charging coil, as well as an output port coupleable to one of a plurality of types of external accessory charging coils of varying shapes and sizes. If the internal charging coil of the external charger is sufficient for a given patient's charging needs, the accessory charging coils may be detached from the external charger, and the external charger may serve as a standalone self-contained external charger. The external charger can automatically detect which of the plurality of types of accessory charging coils is connected, and can adjust its operation accordingly. This versatile design allows the external charger system to be used by large numbers of patients, even if their particular implant charging scenarios are different.

Abstract: An external charger system is disclosed comprising an external charger with an internal charging coil, as well as an output port coupleable to one of a plurality of types of external accessory charging coils of varying shapes and sizes. If the internal charging coil of the external charger is sufficient for a given patient's charging needs, the accessory charging coils may be detached from the external charger, and the external charger may serve as a standalone self-contained external charger. The external charger can automatically detect which of the plurality of types of accessory charging coils is connected, and can adjust its operation accordingly. This versatile design allows the external charger system to be used by large numbers of patients, even if their particular implant charging scenarios are different.